IDSA Guidelines for Using Anti-SARS-CoV-2 Monoclonal Antibody Therapy for Prophylaxis, How Severe Bacterial Infections Develop Following SARS-CoV-2 Infection, and the WHO Research and Development Plan to Combat Endemic Pathogens Including HCV, RSV, and Dengue
Comments 0
Login to view comments.
Click here to Login
